Table: begin end state 1 28 non-cytoplasmic 29 50 transmembrane 51 59 cytoplasmic 60 77 transmembrane 78 87 non-cytoplasmic 88 111 transmembrane 112 122 cytoplasmic 123 144 transmembrane 145 150 non-cytoplasmic 151 170 transmembrane 171 180 cytoplasmic 181 206 transmembrane 207 214 non-cytoplasmic 215 238 transmembrane 239 274 cytoplasmic 275 295 transmembrane 296 300 non-cytoplasmic 301 319 transmembrane 320 330 cytoplasmic 331 352 transmembrane 353 362 non-cytoplasmic 363 383 transmembrane 384 426 cytoplasmic 427 447 transmembrane 448 448 non-cytoplasmic
Input: >PfGW456L13_3595 Citrate-sodium symport MNKPYEQSLKIETASDGGFVQRLRSLCAYEIGVIPLPIFLGIAVIVYLSAHLGFLPKNMI GGLAVIMTMGVFFGQMGSRLPILKEIGGGAILCLMLPSILVFYGFFGPATIDATKMLMKE ANFLYFVIASLVVGSILGMSRFILVQGMLRMFIPLLVGTLAAVASGLIVGKLVGYSFHHT FFFIIVPIIGGGIGEGILPLSLAYSAILGGTPDIYVAQLAPAAVVGNIVAIICAGYLARL ALKRPTINGEGSLIRAKDENDQFLVKEDTGTIVDFRVMGAGVLVICAFFVLGGLLEKVVG IPGPVMMILAAVLFKYLRVLPEKLEKGANSFYKLVSSAFIWPVMIGLGMLYVPLDSVVKV FSVGYVLVCVSVVVSMTVAGFFIGNLMKMYPIESAIVTCCHSGLGGTGDVAILSASNRMS LMPFAQISTRIGGASTVILATILLRLFV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server